New opening! | Pamplona office

April 11, 2024

At Asphalion, we are thrilled to announce the opening of our new office in Pamplona! This strategic decision reflects our commitment to being closer to our clients and strengthening our presence in both national and international markets.

Located in the MISO Centro space, in the heart of Pamplona’s Ensanche, our new office joins our already established headquarters in Barcelona, and our offices in Madrid, Munich, and London. This expansion aims to provide more agile and personalized service to clients in Navarra and the northern region of Spain, showcasing Asphalion’s dedication to excellence and innovation.

The opening of our Pamplona office marks a significant milestone in Asphalion’s growth journey, solidifying our position as a leader in regulatory, scientific, and safety consultancy nationwide. Pamplona stands out as a hub for pharmaceutical and biotechnological companies in Spain, offering a conducive ecosystem for research and development, and its strategic location enhances collaboration opportunities and industry growth.

With a highly skilled team and a customer-centric approach, Asphalion remains steadfast in our mission to deliver comprehensive and tailored solutions that drive our clients’ success in an increasingly competitive and dynamic market.

We are thrilled about this new chapter and reaffirm our commitment to providing top-quality services to our clients in Pamplona, across Spain, and worldwide. Together, let’s forge ahead towards a future of innovation and excellence in the pharmaceutical, biotechnological, and medical device sectors.

Need help, in Pamplona or elsewhere? We´re here for you! info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

HORIZON | siNPAIN meeting in Reykjavík

The objective of this project is to create a siRNA-combined advanced therapy, which will allow a more personalised treatment for different stages of osteoarthritis.  All siNPAIN partners are working hard to develop efficient therapy to improve the quality of life of those affected by osteoarthritis, a chronic joint condition that affects more and more people every year.

NEWS | Proposed framework for International Recognition of Medical Devices by MHRA

This statement describes the draft policy for recognition by the UK of international regulators’ approvals of medical devices.
This statement and proposed framework applies to medical devices in Great Britain. For guidance on the regulation of devices in Northern Ireland, see Regulation of devices in Northern Ireland.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting